72 related articles for article (PubMed ID: 22032858)
21. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
[TBL] [Abstract][Full Text] [Related]
22. Cost of clinical management of acromegaly in Spain.
Roset M; Merino-Montero S; Luque-Ramírez M; Webb SM; López-Mondéjar P; Salinas I; Soto A; Bernal C; Villabona C; De Luis D; Donnay S; Pascual H; Pérez-Luis J;
Clin Drug Investig; 2012 Apr; 32(4):235-45. PubMed ID: 22397307
[TBL] [Abstract][Full Text] [Related]
23. Gamma knife radiosurgery for acromegaly--long-term experience.
Jezková J; Marek J; Hána V; Krsek M; Weiss V; Vladyka V; Lisák R; Vymazal J; Pecen L
Clin Endocrinol (Oxf); 2006 May; 64(5):588-95. PubMed ID: 16649981
[TBL] [Abstract][Full Text] [Related]
24. Biochemical Control in Acromegaly With Multimodality Therapies: Outcomes From a Pituitary Center and Changes Over Time.
Ghajar A; Jones PS; Guarda FJ; Faje A; Tritos NA; Miller KK; Swearingen B; Nachtigall LB
J Clin Endocrinol Metab; 2020 Mar; 105(3):e532-43. PubMed ID: 31701145
[TBL] [Abstract][Full Text] [Related]
25. CyberKnife robotic radiosurgery in the multimodal management of acromegaly patients with invasive macroadenoma: a single center's experience.
Sala E; Moore JM; Amorin A; Martinez H; Bhowmik AC; Lamsam L; Chang S; Soltys SG; Katznelson L; Harsh GR
J Neurooncol; 2018 Jun; 138(2):291-298. PubMed ID: 29429125
[TBL] [Abstract][Full Text] [Related]
26. Comparative effectiveness review of treatment options for pituitary microadenomas in acromegaly.
Marko NF; LaSota E; Hamrahian AH; Weil RJ
J Neurosurg; 2012 Sep; 117(3):522-38. PubMed ID: 22725987
[TBL] [Abstract][Full Text] [Related]
27. [Use of chlorpromazine and trans-sphenoidal micro-surgery in the treatment of acromegaly (dynamic study of growth hormone secretion)].
Lazorthes Y; Bayard F; Zadeh J; Louvet JP
Neurochirurgie; 1973 Dec; 19(7):603-10. PubMed ID: 4792189
[No Abstract] [Full Text] [Related]
28. Long-term treatment outcomes of acromegaly patients presenting biochemically-uncontrolled at a tertiary pituitary center.
Carmichael JD; Broder MS; Cherepanov D; Chang E; Mamelak A; Said Q; Neary MP; Bonert V
BMC Endocr Disord; 2017 Aug; 17(1):49. PubMed ID: 28778166
[TBL] [Abstract][Full Text] [Related]
29. [Acromegaly in 2000].
Gervaise N; Combe H; Lecomte P
Ann Endocrinol (Paris); 2000 Sep; 61(3):242-52. PubMed ID: 10970950
[TBL] [Abstract][Full Text] [Related]
30. Acromegaly: historical perspectives and current therapy.
Jane JA; Thapar K; Laws ER
J Neurooncol; 2001 Sep; 54(2):129-37. PubMed ID: 11761430
[TBL] [Abstract][Full Text] [Related]
31. Clinical presentation and management of acromegaly in elderly patients.
Ceccato F; Barbot M; Lizzul L; Cuccarollo A; Selmin E; Merante Boschin I; Daniele A; Saller A; Occhi G; Regazzo D; Scaroni C
Hormones (Athens); 2021 Mar; 20(1):143-150. PubMed ID: 32840821
[TBL] [Abstract][Full Text] [Related]
32. The German Acromegaly Registry: description of the database and initial results.
Reincke M; Petersenn S; Buchfelder M; Gerbert B; Skrobek-Engel G; Franz H; Lohmann R; Quabbe HJ
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):498-505. PubMed ID: 17115347
[TBL] [Abstract][Full Text] [Related]
33. The association between biochemical control and cardiovascular risk factors in acromegaly.
Carmichael JD; Broder MS; Cherepanov D; Chang E; Mamelak A; Said Q; Neary MP; Bonert V
BMC Endocr Disord; 2017 Mar; 17(1):15. PubMed ID: 28279153
[TBL] [Abstract][Full Text] [Related]
34. Acromegaly.
Ben-Shlomo A; Melmed S
Endocrinol Metab Clin North Am; 2008 Mar; 37(1):101-22, viii. PubMed ID: 18226732
[TBL] [Abstract][Full Text] [Related]
35. [Acromegaly. Report of 84 cases].
Martínez-Delgado IA; Gómez-Martínez G
Rev Med Inst Mex Seguro Soc; 2008; 46(3):311-4. PubMed ID: 19133209
[TBL] [Abstract][Full Text] [Related]
36. Predictors and rates of treatment-resistant tumor growth in acromegaly.
Besser GM; Burman P; Daly AF
Eur J Endocrinol; 2005 Aug; 153(2):187-93. PubMed ID: 16061822
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal assessment of economic burden and clinical outcomes in acromegaly.
Wilson LS; Shin JL; Ezzat S
Endocr Pract; 2001; 7(3):170-80. PubMed ID: 11421563
[TBL] [Abstract][Full Text] [Related]
38. [Croatian Society of Endocrinology guidelines for the diagnosis and treatment of acromegaly].
Kastelan D; Dusek T; Vizner B; Gnjidić Z; Orlić ZC; Kusec V; Heinrich Z; Vrkljan M; Korsić M;
Lijec Vjesn; 2012; 134(3-4):65-8. PubMed ID: 22768678
[TBL] [Abstract][Full Text] [Related]
39. High Prevalence of Acromegaly in Different Industrial Areas: A Population-based Study from Haifa and Western Galilee District in Northern Israel.
Zaina A; Shimon I; Abid A; Arad E; Baron E; Golden E; Gershinsky M; Saba Khazen N; Abu Saleh M; Roguin Maor N; Bardicef O; Pauker Y; Kassem S
Isr Med Assoc J; 2022 Jul; 24(7):448-453. PubMed ID: 35819213
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Nephrolithiasis Treatment in Highest Reference Hospital-Occurrence of Acromegaly in the Study Group.
Ząbkowski T; Durma AD; Grabińska A; Michalczyk Ł; Saracyn M
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
